The Double-Edged Sword in Pathogenic Trypanosomatids: The Pivotal Role of Mitochondria in Oxidative Stress and Bioenergetics

被引:108
作者
Sadok Menna-Barreto, Rubem Figueiredo [1 ]
de Castro, Solange Lisboa [1 ]
机构
[1] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Celular, BR-21040360 Manguinho, RJ, Brazil
关键词
PROGRAMMED CELL-DEATH; LEISHMANIA-DONOVANI PROMASTIGOTES; RESPIRATORY-CHAIN; ALTERNATIVE OXIDASE; DNA TOPOISOMERASE; BLOOD-STREAM; SUPEROXIDE-DISMUTASE; KINETOPLASTID PARASITES; PROTEOMIC ANALYSIS; REACTIVE OXYGEN;
D O I
10.1155/2014/614014
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The pathogenic trypanosomatids Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp. are the causative agents of African trypanosomiasis, Chagas disease, and leishmaniasis, respectively. These diseases are considered to be neglected tropical illnesses that persist under conditions of poverty and are concentrated in impoverished populations in the developing world. Novel efficient and nontoxic drugs are urgently needed as substitutes for the currently limited chemotherapy. Trypanosomatids display a single mitochondrion with several peculiar features, such as the presence of different energetic and antioxidant enzymes and a specific arrangement of mitochondrial DNA(kinetoplast DNA). Due to mitochondrial differences between mammals and trypanosomatids, this organelle is an excellent candidate for drug intervention. Additionally, during trypanosomatids' life cycle, the shape and functional plasticity of their single mitochondrion undergo profound alterations, reflecting adaptation to different environments. In an uncoupling situation, the organelle produces high amounts of reactive oxygen species. However, these species role in parasite biology is still controversial, involving parasite death, cell signalling, or even proliferation. Novel perspectives on trypanosomatid-targeting chemotherapy could be developed based on better comprehension of mitochondrial oxidative regulation processes.
引用
收藏
页数:14
相关论文
共 152 条
[1]  
Alberts B., 2002, The shape and structure of proteins, Vfourth, DOI 10.1093/aob/mcg023
[2]   Proteomic analysis of Trypanosoma cruzi resistance to benznidazole [J].
Andrade, Helida M. ;
Murta, Silvane M. F. ;
Chapeaurouge, Alex ;
Perales, Jonas ;
Nirde, Phillipe ;
Romanha, Alvaro J. .
JOURNAL OF PROTEOME RESEARCH, 2008, 7 (06) :2357-2367
[3]  
[Anonymous], J INTEGR OMICS
[4]  
[Anonymous], 2012, GLOB REP RES INF DIS
[5]   The Trypanosoma cruzi proteome [J].
Atwood, JA ;
Weatherly, DB ;
Minning, TA ;
Bundy, B ;
Cavola, C ;
Opperdoes, FR ;
Orlando, R ;
Tarleton, RL .
SCIENCE, 2005, 309 (5733) :473-476
[6]   Management of trypanosomiasis and leishmaniasis [J].
Barrett, Michael P. ;
Croft, Simon L. .
BRITISH MEDICAL BULLETIN, 2012, 104 (01) :175-196
[7]   Recent advances in identifying and validating drug targets in trypanosomes and leishmanias [J].
Barrett, MP ;
Mottram, JC ;
Coombs, GH .
TRENDS IN MICROBIOLOGY, 1999, 7 (02) :82-88
[8]   Protein translocation into mitochondria: the role of TIM complexes [J].
Bauer, MF ;
Hofmann, S ;
Neupert, W ;
Brunner, M .
TRENDS IN CELL BIOLOGY, 2000, 10 (01) :25-31
[9]   An unusual type IB topoisomerase from African trypanosomes [J].
Bodley, AL ;
Chakraborty, AK ;
Xie, SJ ;
Burri, C ;
Shapiro, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7539-7544
[10]   MOLECULAR AND CYTOTOXIC EFFECTS OF CAMPTOTHECIN, A TOPOISOMERASE-I INHIBITOR, ON TRYPANOSOMES AND LEISHMANIA [J].
BODLEY, AL ;
SHAPIRO, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :3726-3730